Showing results (2701-2710 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|March 15, 2022
Heart failure quality of care and in-hospital outcomes during the COVID-19 pandemic: findings from the Get With The Guidelines-Heart Failure registryNeil Keshvani, Anurag Mehta, Heather M Alger, et al.
European Journal of Heart Failure|March 16, 2022
The association of improvement in left ventricular ejection fraction with outcomes in patients with heart failure with reduced ejection fraction: data from CHAMP-HFAdam D DeVore, Anne S Hellkamp, Laine Thomas, et al.
European Journal of Heart Failure|March 25, 2022
Responder analysis for improvement in 6-min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiencyStefan D Anker, Piotr Ponikowski, Muhammad Shahzeb Khan, et al.
European Journal of Heart Failure|March 26, 2022
Characteristics and outcomes of patients screened for transcatheter mitral valve implantation: 1-year results from the CHOICE-MI registryWalid Ben Ali, Sebastian Ludwig, Alison Duncan, et al.
European Journal of Heart Failure|April 2, 2022
Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK BiobankTripti Rastogi, Frederick K Ho, Patrick Rossignol, et al.
European Journal of Heart Failure|March 1, 2022
The response to cardiac resynchronization therapy in LMNA cardiomyopathyKiran Sidhu, Anna Isotta Castrini, Victoria Parikh, et al.
European Journal of Heart Failure|September 20, 2018
Telemedical Interventional Management in Heart Failure II (TIM-HF2), a randomised, controlled trial investigating the impact of telemedicine on unplanned cardiovascular hospitalisations and mortality in heart failure patients: study design and description of the interventionFriedrich Koehler, Kerstin Koehler, Oliver Deckwart, et al.
European Journal of Heart Failure|September 19, 2018
Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fractionAdriaan A Voors, Sanjiv J Shah, Jeroen J Bax, et al.
European Journal of Heart Failure|September 19, 2018
Is mild asymptomatic left ventricular systolic dysfunction always predictive of adverse events in high-risk populations? Insights from the DAVID-Berg studyMauro Gori, Margaret M Redfield, Alice Calabrese, et al.
European Journal of Heart Failure|September 27, 2018
Impact of exercise-based cardiac rehabilitation in patients with heart failure (ExTraMATCH II) on mortality and hospitalisation: an individual patient data meta-analysis of randomised trialsRod S Taylor, Sarah Walker, Neil A Smart, et al.
Pageof 398